Despite the successes of current coronavirus disease 2019 (COVID-19) vaccines, waning immunity, the emergence of variants of concern, and breakthrough infections among …
SI Richardson, P Kgagudi, NP Manamela… - Cell Reports …, 2023 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA. 4 and BA. 5 variants caused major waves of infections. Here, we assess the sensitivity of BA. 4 to …
T Moyo-Gwete, M Madzivhandila, NN Mkhize… - Journal of …, 2022 - Am Soc Microbiol
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, several variants of concern (VOCs) have arisen which are defined by multiple mutations in …
A Tauzin, G Beaudoin-Bussières, SY Gong… - Iscience, 2022 - cell.com
Summary Although SARS-CoV-2 mRNA vaccination has been shown to be safe and effective in the general population, immunocompromised solid organ transplant recipients …
A Banerjee, J Lew, A Kroeker, K Baid, P Aftanas… - Med, 2022 - cell.com
Summary Background SARS-CoV-2 Omicron variant of concern (VOC) has evolved multiple mutations within the spike protein, raising concerns of increased antibody evasion. In this …
I Ullah, F Escudie, I Scandale, Z Gilani… - Iscience, 2024 - cell.com
Direct acting antivirals (DAAs) represent critical tools for combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) that have escaped …
The emergence of novel SARS-CoV-2 variants led to the recommendation of booster vaccinations after Ad26. COV2. S priming. It was previously shown that heterologous …
The continued evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates that the global scientific community monitor, assess, and respond to the …